combo product called Stalevo will allow patients with Parkinson's disease to take fewer tablets

A new combo product called Stalevo will allow patients with Parkinson's disease to take fewer tablets.

It contains both standard-release carbidopa/levodopa (Sinemet, etc)...PLUS entacapone (Comtan).

Stalevo will be for patients who already take these drugs separately...or for patients who have "wearing-off" on levodopa. Adding entacapone boosts efficacy of levodopa and helps it last longer.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get quote